# US 2022/0034867 A1 · Devices and methods for single cell analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0034867 A1
- Document ID: US20220034867A1
- Status: Published application
- Kind: A1
- Application number: 17/201,763
- Filed: 2021-03-15
- Published: 2022-02-03
- Earliest claimed: 2012-09-26
- Assignees: Quantumcyte, Inc.
- Applicants: Quantumcyte, Inc.
- Inventors: John Butler; Bidhan Chaudhuri
- Web page: https://patentgrep.com/patent/US20220034867A1

## CPC

- G01N 33/5011: {for testing antineoplastic activity}
- C12N 5/0693: {Tumour cells; Cancer cells}
- C12N 11/08: the carrier being a synthetic polymer
- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- G01N 33/5041: {involving analysis of members of signalling pathways}
- C12N 2533/40: Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
- C12N 2537/10: Cross-linking
- G01N 2500/10: involving cells
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present disclosure provides systems, methods, and devices for the simultaneous determination of a single cell's response to a stimuli and characterization of its cell response. The present disclosure further provides methods for detection of disease state, clinical management of a subject suffering from a disease, drug screening, prediction of drug response, and stands to help direct drug and diagnostic development for the treatment of disease.

## Claims

### Claim 1

(canceled)

### Claim 2

A method of agent transfer comprising:
providing a plurality of cells from a biological sample comprising a heterogenous population of cells from a patient positioned on a surface of a first solid substrate at a plurality of cell-philic sites;
immobilizing a portion of the cells in a hydrogel concentration at their respective cell-philic sites thereby creating a plurality of three-dimensional cell microenvironments comprising the hydrogel composition and the cells, the hydrogel composition of each three-dimensional cell microenvironment being sized and positioned so as to extend upward with a dome shape from the surface of the solid substrate;
dispending an agent onto an agent transfer device comprising a plurality of agent transfer array elements positioned on a surface of a second solid substrate; and
contacting the plurality of agent transfer array elements to the plurality of three-dimensional cell microenvironments, such that each agent transfer array element corresponds to a three-dimensional cell microenvironment, wherein the contacting allows the agent to be transferred to the plurality of three-dimensional cell microenvironments,

### Claim 3 (depends on 2)

The method of claim 2, wherein the agent transfer device transfers at least 50% of the original concentration of the agent on the agent transfer device to the plurality of three-dimensional cell microenvironments.

### Claim 4 (depends on 2)

The method of claim 2, wherein the plurality of cells comprise a clinical sample.

### Claim 5 (depends on 2)

The method of claim 2, wherein the plurality of cells comprise a tumor biopsy.

### Claim 6 (depends on 2)

The method of claim 2, wherein the plurality of cells comprise fixed tissue.

### Claim 7 (depends on 2)

The method of claim 2, wherein the hydrogel composition comprises a cross-linked hydrogel.

### Claim 8 (depends on 7)

The method of claim 7, wherein the cross-linked hydrogel comprises a poly(ethylene glycol) (PEG) hydrogel composition.

### Claim 9 (depends on 2)

The method of claim 2, wherein the hydrogel composition comprises Poly(ethylene glycol)bis(acrylate) 10 KDa (Bis Acryl PEG 10k) or acrylate poly(ethylene glycol) N-hydroxysuccinimidyl ester 3,4 KDa (Acryl/NHS PEG3,4K).

### Claim 10 (depends on 2)

The method of claim 2, wherein the agent is a polynucleotide.

### Claim 11 (depends on 2)

The method of claim 2, wherein the agent is a small molecule.

### Claim 12 (depends on 2)

The method of claim 2, wherein the cell-philic site comprises 1-100 μM in diameter.

### Claim 13 (depends on 2)

The method of claim 2, wherein immobilizing the portion of the cells further comprises applying ultraviolet light to the array to crosslink the three-dimensional cell microenvironment.

### Claim 14 (depends on 2)

The method of claim 2, wherein the plurality of cell-philic sites are separated from each other by one or more hydrophobic regions.

### Claim 15 (depends on 2)

The method of claim 2, wherein the plurality of agent transfer array elements comprise a cross-linked hydrogel.

### Claim 16 (depends on 15)

The method of claim 15, wherein the cross-linked hydrogel comprises a poly(ethylene glycol) (PEG) hydrogel composition.
